M30K (p.Met30Lys) variant of PKD2 (Polycystin-2)

M30K (p.Met30Lys) in PKD2 (Polycystin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Polycystic kidney disease 2. The available variant effect predictions contribute to a CATVariant prioritization score of 0.13 / 1. The record also includes population frequency data and structural context.

M30K (p.Met30Lys) variant details